Clinical Trials Browser

Phase 2 × Autistic Disorder × Sirolimus × Clear all

NCT01929642 2021-03-29

RAPT

Phase 2 Completed

3 enrolled 10 charts

Autistic Disorder, Tuberous Sclerosis, Self-Injurious Behavior